ARTICLE | Clinical News
HDM-SPIRE: Ph IIb data
April 21, 2017 8:34 PM UTC
Top-line data from a double-blind, international Phase IIb trial in 714 house dust mite allergic patients with moderate or severe allergy symptoms showed that 12 and 20 nmol HDM-SPIRE every 4 weeks fo...
BCIQ Company Profiles